Antoine Italiano
University of Bordeaux
528 Papers
1.1K Citations
Antoine Italiano is an academic researcher from University of Bordeaux. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 56, co-authored 366 publications. Previous affiliations of Antoine Italiano include Argonne National Laboratory & French Institute of Health and Medical Research.
Chat about Author
Papers
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib
Samuel Hidalgo-Rios,Jaime Carrillo-García,David S. Moura,Silvia Stacchiotti,Antonio Lopez-Pousa,Andrés Redondo,Antoine Italiano,Ana Gutiérrez,Giovanni Grignani,Nadia Hindi,José Antonio López-Guerrero,X. Garcia del Muro,Javier Martínez Trufero,Emanuela Palmerini,Ana García,Daniel Bernabeu,Axel Le Cesne,Paolo G. Casali,Jean-Yves Blay,J. Cruz Jurado,Javier Martin-Broto +20 more
TL;DR: Pazopanib treatment in advanced solitary fibrous tumour patients, assessed in the prospective GEIS-32 phase II clinical trial, has shown longer progression-free survival and overall survival versus chemotherapy treatment in control patients.
Clonal hematopoiesis (CH) associated mutations in patients with advanced solid tumors enrolled in phase I clinical trials.
J. E. Rodriguez,A. Bayle,Arnaud Pagès,François-Xavier Danlos,D. Le Vasseur,Etienne Rouleau,Ludovic Lacroix,B. Alonso de Castro,Vincent Goldschmidt,Lauren Seknazi,Antoine Hollebecque,Jean Michon,Stéphane Champiat,Aurélien Marabelle,Kaïssa Ouali,Christophe Marzac,Santiago Ponce Aix,Antoine Italiano,Jean-Baptiste Micol,Capucine Baldini +19 more
TL;DR: In this article , an increased number of CH associated mutations has been identified in patients (pts) with solid tumors, and their impact on patients' outcomes remains unclear, however, the authors aim to integrate molecular data and clinical characteristics of CH in pts enrolled in clinical trials.
High Dose (54 Gy) Pre-Operative Helical Tomotherapy for Retroperitoneal Liposarcoma: Results of a Phase II Multicenter Study.
Paul Sargos,Eberhard Stoeckle,Anne Ducassou,Antoine Giraud,A. Mervoyer,Antoine Italiano,S. Albert,Gwenael Ferron,Carine Bellera,Guy Kantor +9 more
TL;DR: In this article , the authors evaluated the feasibility of high-dose intensity-modulated radiotherapy (RT) with pre-operative helical tomotherapy, delivering 54 Gy/30 fractions in patients with retroperitoneal liposarcomas (RPLS).
Abstract 622: Development and characterization of a novel anti-PD1 resistant sarcoma mouse model
Imane Nafia,Jean-Philippe Guégan,Assia Chaibi,Noëlie Bos,Doriane Bortolotto,Christophe Rey,Loïc Cerf,Florent Peyraud,Antoine Italiano,Alban Bessede +9 more
TL;DR: A novel preclinical mouse model of sarcoma characterized by its resistance to anti-PD1 and a high tumor infiltration by macrophages is developed and validated and can serve to evaluate novel immunotherapeutic regimens either alone or in combination with reference ICI.
Expression of Concern to: Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition.
Benjamin Fourneaux,Benjamin Fourneaux,Aurélien Bourdon,Bérengère Dadone,Carlo Lucchesi,Scott R. Daigle,Elodie Richard,Elodie Richard,Audrey Laroche-Clary,Audrey Laroche-Clary,François Le Loarer,Antoine Italiano +11 more
TL;DR: The Editor-in-Chief would like to alert readers that the ownership of some of the data presented in this article is the property of the author and not the publisher.